GB1025862A - Improvements in or relating to anti-inflammatory compositions - Google Patents
Improvements in or relating to anti-inflammatory compositionsInfo
- Publication number
- GB1025862A GB1025862A GB23407/63A GB2340763A GB1025862A GB 1025862 A GB1025862 A GB 1025862A GB 23407/63 A GB23407/63 A GB 23407/63A GB 2340763 A GB2340763 A GB 2340763A GB 1025862 A GB1025862 A GB 1025862A
- Authority
- GB
- United Kingdom
- Prior art keywords
- inflammatory compositions
- relating
- enzymes
- enzyme
- esterasic
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 230000003110 anti-inflammatory effect Effects 0.000 title abstract 2
- 239000000203 mixture Substances 0.000 title abstract 2
- 108090000790 Enzymes Proteins 0.000 abstract 4
- 102000004190 Enzymes Human genes 0.000 abstract 4
- 229940088598 enzyme Drugs 0.000 abstract 4
- 239000004365 Protease Substances 0.000 abstract 2
- BSYNRYMUTXBXSQ-UHFFFAOYSA-N Aspirin Chemical class CC(=O)OC1=CC=CC=C1C(O)=O BSYNRYMUTXBXSQ-UHFFFAOYSA-N 0.000 abstract 1
- 108010004032 Bromelains Proteins 0.000 abstract 1
- 108090000317 Chymotrypsin Proteins 0.000 abstract 1
- 108090000270 Ficain Proteins 0.000 abstract 1
- 108090000526 Papain Proteins 0.000 abstract 1
- 108090000631 Trypsin Proteins 0.000 abstract 1
- 102000004142 Trypsin Human genes 0.000 abstract 1
- 229960001138 acetylsalicylic acid Drugs 0.000 abstract 1
- 230000003625 amylolytic effect Effects 0.000 abstract 1
- 229960002376 chymotrypsin Drugs 0.000 abstract 1
- 239000002702 enteric coating Substances 0.000 abstract 1
- 238000009505 enteric coating Methods 0.000 abstract 1
- 230000003480 fibrinolytic effect Effects 0.000 abstract 1
- 235000019836 ficin Nutrition 0.000 abstract 1
- POTUGHMKJGOKRI-UHFFFAOYSA-N ficin Chemical compound FI=CI=N POTUGHMKJGOKRI-UHFFFAOYSA-N 0.000 abstract 1
- 230000003301 hydrolyzing effect Effects 0.000 abstract 1
- 239000002184 metal Chemical class 0.000 abstract 1
- 229940055729 papain Drugs 0.000 abstract 1
- 235000019834 papain Nutrition 0.000 abstract 1
- 230000002797 proteolythic effect Effects 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 239000012588 trypsin Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/60—Salicylic acid; Derivatives thereof
- A61K31/612—Salicylic acid; Derivatives thereof having the hydroxy group in position 2 esterified, e.g. salicylsulfuric acid
- A61K31/616—Salicylic acid; Derivatives thereof having the hydroxy group in position 2 esterified, e.g. salicylsulfuric acid by carboxylic acids, e.g. acetylsalicylic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
- A61K38/4873—Cysteine endopeptidases (3.4.22), e.g. stem bromelain, papain, ficin, cathepsin H
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/465—Hydrolases (3) acting on ester bonds (3.1), e.g. lipases, ribonucleases
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/47—Hydrolases (3) acting on glycosyl compounds (3.2), e.g. cellulases, lactases
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
- A61K38/482—Serine endopeptidases (3.4.21)
- A61K38/4826—Trypsin (3.4.21.4) Chymotrypsin (3.4.21.1)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
- C12Y304/21—Serine endopeptidases (3.4.21)
- C12Y304/21001—Chymotrypsin (3.4.21.1)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
- C12Y304/22—Cysteine endopeptidases (3.4.22)
- C12Y304/22002—Papain (3.4.22.2)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
- C12Y304/22—Cysteine endopeptidases (3.4.22)
- C12Y304/22033—Fruit bromelain (3.4.22.33), i.e. juice bromelain
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Gastroenterology & Hepatology (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CH699362 | 1962-06-12 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GB1025862A true GB1025862A (en) | 1966-04-14 |
Family
ID=4318246
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GB23407/63A Expired GB1025862A (en) | 1962-06-12 | 1963-06-12 | Improvements in or relating to anti-inflammatory compositions |
Country Status (3)
| Country | Link |
|---|---|
| US (1) | US3627875A (enExample) |
| FR (1) | FR2833M (enExample) |
| GB (1) | GB1025862A (enExample) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2556218A1 (fr) * | 1983-12-12 | 1985-06-14 | Gerard Alain | Produit pharmaceutique pour application locale constitue par l'association d'un principe actif medicamenteux-agent enzymatique |
| US8183284B2 (en) | 2005-07-22 | 2012-05-22 | Warner Chilcott Company, Llc | Compositions for reducing the incidence of drug induced arrhythmia |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4250167A (en) * | 1978-09-19 | 1981-02-10 | Davis Elgan A | Methods for reducing calcium deposits |
| US4444751A (en) * | 1981-09-14 | 1984-04-24 | Vannguard Of Hampton, Inc. | Neutralizing composition for sting venoms |
| FR2833173B1 (fr) * | 2001-12-10 | 2004-08-27 | Roquette Freres | Preparation antipyretique renfermant du xylitol |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US1746984A (en) * | 1927-10-31 | 1930-02-11 | William C Bausch | Vehicle for acetyl-salicylic acid tablets |
| US2040848A (en) * | 1932-12-22 | 1936-05-19 | Hirschhorn Louis | Acetyl salicylic acid solution and method of producing the same |
| US3072532A (en) * | 1958-11-04 | 1963-01-08 | Innerfield Irving | Administration of enzymic composition |
| US3004893A (en) * | 1959-10-21 | 1961-10-17 | Richardson Merrell Inc | Enteric coated trypsin and chymotrypsin anti-inflammatory compositions |
-
1963
- 1963-05-04 FR FR7743A patent/FR2833M/fr not_active Expired
- 1963-05-15 US US255117A patent/US3627875A/en not_active Expired - Lifetime
- 1963-06-12 GB GB23407/63A patent/GB1025862A/en not_active Expired
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2556218A1 (fr) * | 1983-12-12 | 1985-06-14 | Gerard Alain | Produit pharmaceutique pour application locale constitue par l'association d'un principe actif medicamenteux-agent enzymatique |
| US8183284B2 (en) | 2005-07-22 | 2012-05-22 | Warner Chilcott Company, Llc | Compositions for reducing the incidence of drug induced arrhythmia |
Also Published As
| Publication number | Publication date |
|---|---|
| FR2833M (enExample) | 1964-10-05 |
| US3627875A (en) | 1971-12-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE2967581D1 (en) | Determination of proteolytic enzymes in body fluids and fluorogenic substrates | |
| CA1019724A (en) | Substrates for diagnostic use, with high susceptibility to trypsin and other proteolytic enzymes of the type peptide peptidohydrolases | |
| GB1243784A (en) | Proteolytic enzymes, their production and use | |
| IL48506A (en) | Chromogenic enzyme substrates for serine proteases | |
| AU553654B2 (en) | Combination of fungal protease and pancreatin to enzymatically hydrolyse protein | |
| DK98090A (da) | Enzymatiske detergentsammensaetninger | |
| CA1010849A (en) | Substrates for diagnostic use, with high susceptibility to thrombin and other proteolytic enzymes of the type peptide peptidohydrolases | |
| ES8601658A1 (es) | Un procedimiento para aumentar el rendimiento y la solubilidad de componentes solidos del te negro por tratamiento enzimatico | |
| BE789195A (fr) | Compositions d'enzymes | |
| IL47554A (en) | Substrate for the quantitative determination of proteolytic enzymes of class e.c.3.4.4. | |
| AU523744B2 (en) | Detection of esterolytic and/or proteolytic enzymes | |
| AU541968B2 (en) | Thermostable micro-organism and proteolytic enzyme | |
| BR6791131D0 (pt) | Processo para produzir colagenase e composicao enzimatica tendo atividade de enzima proteolitica e de colagenase | |
| ES2196436T3 (es) | Acidos sulfonilalcanoilamino-hidroxietilamino-sulfamicos utiles como inhibidores de proteasas retrovirales. | |
| DK120284A (da) | Fremgangsmaade til fermentering af en enzymproducerende mikroorganisme, der kan producere protease og amylase | |
| DE3276909D1 (en) | Enzymatic contact lens cleaning product with ph-controlled activity | |
| GB1025862A (en) | Improvements in or relating to anti-inflammatory compositions | |
| DE59009945D1 (de) | Mittel zur hemmung von hiv-proteasen. | |
| ES486658A1 (es) | Procedimiento para el tratamiento de pellejos con enzimas proteoliticas | |
| JPS5225087A (en) | Method of rendering alkaline phosphatase activity unchageable and control serum containtaining said enzyme | |
| ES391930A1 (es) | Procedimiento para el remojo de pellejos y cueros. | |
| FR2057030A7 (en) | Cosmetic compsn with microencapsulated - enzymes | |
| GB1357164A (en) | Enzymatic aerosol compositions | |
| ES470603A1 (es) | Un procedimiento de preparacion de extracto de levadura de bakers de coacps | |
| GB1099446A (en) | Acid active stable amylase |